In lung cancer cells, EGLN1 and c-Myc are recruited to the promoter of lymphoid-specific helicase (LSH) at two hypoxia inducible factor-1α (HIF-1α) binding sites, which directly facilitates the expression of LSH by inhibiting HIF-1α115. This evidence concerns the gene HELLS and lung carcinoma.